These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22314205)

  • 1. Response as an end point in treatment trials for acute GVHD.
    Pavletic SZ
    Bone Marrow Transplant; 2012 Feb; 47(2):161-3. PubMed ID: 22314205
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL; Bloom EJ
    Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals.
    Taupin P
    Curr Opin Investig Drugs; 2006 May; 7(5):473-81. PubMed ID: 16729725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Auletta JJ; Cooke KR
    Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of acute GvHD--new modalities.
    Hervé P
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):295-7. PubMed ID: 8337146
    [No Abstract]   [Full Text] [Related]  

  • 6. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
    Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
    Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
    Herbelin C; Stephan JL; Donadieu J; Le Deist F; Racadot E; Wijdenes J; Fischer A
    Bone Marrow Transplant; 1994 May; 13(5):563-9. PubMed ID: 8054909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the treatment of steroid-resistant acute graft-versus-host disease.
    Tse JC; Moore TB
    Pharmacotherapy; 1998; 18(5):988-1000. PubMed ID: 9758310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease.
    Vogelsang GB; Wagner JE
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):625-39. PubMed ID: 2193015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation?
    Ghosh K; Hutchinson RM
    Haematologia (Budap); 1996; 28(1):45-51. PubMed ID: 9283904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graft vs host disease in a child undergoing allogeneic bone marrow transplantation].
    Nespoli L; Locatelli F
    Pediatr Med Chir; 1991; 13(1):17-23. PubMed ID: 2052451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute GVHD: pathogenesis, symptomatology, stage/severity, and treatment].
    Imamura M; Miyazaki T; Kasai M
    Nihon Rinsho; 1990 Sep; 48(9):2055-60. PubMed ID: 2232210
    [No Abstract]   [Full Text] [Related]  

  • 17. How best to analyse new strategies in bone marrow transplantation.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Dec; 6(6):357-9. PubMed ID: 2097005
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
    Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
    Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.
    Roy J; McGlave PB; Filipovich AH; Miller WJ; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1992 Jul; 10(1):77-82. PubMed ID: 1515883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.